The standard cagrilintide monotherapy titration follows this schedule: 0.25 mg weekly for weeks 1-4, then 0.5 mg for weeks 5-8, then 1.0 mg for weeks 9-12, then 1.7 mg for weeks 13-16, and finally 2.4 mg for week 17 onward as the maintenance dose
And I have a really good story that I can share
Most people experiencing injection site reactions can successfully continue their dosing protocols by: Optimizing injection technique: Aggressive dilution (3mL+), strict rotation (1-2 cm spacing), slow injection, room temperature peptides, 4mm needles Pre-treating reactive injections: Benadryl cream applied one minute before injection Keeping KPV as insurance: 500mcg immediately after reactive injections Addressing root causes: Healing gut, supporting DAO levels, optimizing estradiol readings, correcting nutrient deficiencies Taking methodical approach to stacking: Testing individual peptides before combining, building tolerance progressively Research across thousands of patients confirms that treatment discontinuation due to injection site reactions is extremely rare
Research involving experimental animal systems, including mice, continues to play an important role in advancing understanding of regenerative biology
Bacteriostatic water for peptide reconstitution and injection (One bottle will last many months of weekly peptide research) 30ml Enough to constitute approximately 15+ Peptide Vials.